[Evaluation of the benefit/risk relationship of a non-steroidal anti-inflammatory drug before its marketing]
Rev Rhum Mal Osteoartic
.
1989 Jan;56(1):67-9.
[Article in French]
Authors
B Bannwarth
1
,
B Avouac
,
P Netter
Affiliation
1
URA CNRS 1288, CHU de Nancy-Brabois.
PMID:
2657993
No abstract available
Publication types
Clinical Trial
MeSH terms
Animals
Anti-Inflammatory Agents, Non-Steroidal*
Clinical Trials as Topic
Drug Evaluation
Humans
Risk Factors
Substances
Anti-Inflammatory Agents, Non-Steroidal